<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
	"http://www.w3.org/TR/1998/REC-html40-19980424/loose.dtd">
<html>
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8">
<style type="text/css">
 table.main {}
 tr.row {}
 td.cell {}
 div.block {}
 div.paragraph {}
 .font0 { font:6pt Arial, sans-serif; }
 .font1 { font:7pt Arial, sans-serif; }
 .font2 { font:10pt Times New Roman, serif; }
 .font3 { font:15pt Times New Roman, serif; }

</style>
</head>
<body>
<p><span class="font3">JPMorgan</span></p>
<p><span class="font1" style="font-weight:bold;">Asia Pacific Equity Research</span></p>
<p><span class="font1" style="font-weight:bold;">07 September 2016</span></p>
<p><span class="font1" style="font-weight:bold;">Isabella Y. Zhao, CFA</span></p>
<p><span class="font1" style="font-weight:bold;">(852) 2800-8534</span></p>
<p><a href="mailto:isabella.2hao@jpmorgan.com"><span class="font1" style="font-weight:bold;">isabella.2hao@jpmorgan.com</span></a></p>
<p><a name="bookmark0"></a><span class="font2" style="font-weight:bold;"><a name="bookmark1"></a>Premium for simplicity and track record Yet Fully Priced in Growth Potential</span></p>
<p><span class="font2">We believe that Sinopharm trades at a significant premium to most healthcare companies in China due to the simplicity and stability of its business. Sinopharm has shown for the past years that it can grow faster than the overall market, consistently increasing market share and maintaining a relatively stable gross margin. Yet, Sinopharm has appreciated by 20% YTD in 2016 vs MSCI China Healthcare index down by 6% YTD, we see a few reasons for this upswing: 1) increasing investor risk aversion with preference for large and liquid stocks; 2) the continued strong above industry average growth. The MSCI China Healthcare Index is trading at its lower forward P/E level, re-rating is possible. Yet, Trading at 19x 2017 P/E vs. 17% EPS CAGR in 2015-2018E, we believe its growth potential is largely priced in.</span></p>
<p><span class="font0">Source: Bloomberg</span></p>
<p><span class="font1">6</span></p>
</body>
</html>